Exane Derivatives’s DocuSign DOCU Stock Holding History

Exane Derivatives’s Portfolio DOCU Stock Details DOCU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$10.3K	Hold	179	–	–	0.01%	389
2022 Q1	$19.2K	Hold	179	–	–	0.01%	664
2021 Q4	$27.3K	Sell	179 -790	-82%	-$180K	0.01%	556
2021 Q3	$249K	Buy	969 +90	+10%	+$25.9K	0.06%	337
2021 Q2	$249K	Buy	879 +161	+22%	+$36K	0.06%	342
2021 Q1	$145K	Sell	718 -3,334	-82%	-$773K	0.04%	343
2020 Q4	$901K	Sell	4,052 -182	-4%	-$40.9K	0.26%	98
2020 Q3	$911K	Buy	4,234 +934	+28%	+$194K	0.26%	94
2020 Q2	$568K	Buy	+3,300	New	+$416K	0.15%	116

Other funds holding DOCU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Exane Derivatives's DOCU Position: Q2 2022 in Review

Exane Derivatives held its DocuSign (DOCU) position steady in Q2 2022 at 179 shares worth $10.3K. The position accounts for 0.01% of the portfolio, ranked #389.

Exane Derivatives first reported a position in DOCU in Q2 2020 and has held it in 9 quarters since. The position peaked at $911K in Q3 2020. 791 funds tracked by Wall St. Rank hold DOCU as of Q2 2022.

Exane Derivatives held 179 shares of DocuSign worth $10.3K as of Q2 2022.
Exane Derivatives left its DocuSign share count unchanged in Q2 2022.
DocuSign made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #389 holding.
Exane Derivatives first reported a position in DocuSign in Q2 2020 and has held it in 9 quarters since.
Exane Derivatives's DocuSign position peaked at $911K in Q3 2020.
791 funds tracked by Wall St. Rank held DocuSign as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.